多变量ELISA用于自身免疫性大疱病常规诊断的前瞻性研究
该研究评估一种包含6种重组抗原的多变量ELISA在自身免疫性大疱病(AIBD)常规诊断中的价值。在三个队列中与直接免疫荧光和传统多步诊断算法比较,显示天疱疮符合率94%、类天疱疮71%,与传统方法符合率91%和88%。结论认为该ELISA是实用、高度标准化且广泛可用的新诊断工具。
要点
- 多变量ELISA与直接免疫荧光在天疱疮中符合率94%,类天疱疮71%。
- 与传统多步诊断算法符合率:天疱疮91%,大疱性类天疱疮88%。
- 该ELISA可作为AIBD常规诊断的实用标准化工具。
核心结论
- 多变量ELISA是实用、高度标准化且广泛可用的AIBD常规诊断新工具。
研究设计与样本
- 研究采用三个队列:明确诊断的AIBD血清173例和对照血清130例;前瞻性多中心新诊断AIBD且直接免疫荧光阳性的血清204例;前瞻性单中心临床怀疑AIBD的连续血清292例。
- 多变量ELISA包含6种重组免疫优势抗原:桥粒芯蛋白1、桥粒芯蛋白3、包斑蛋白、BP180、BP230和VII型胶原。
主要发现
- 与直接免疫荧光比较,多变量ELISA在天疱疮患者中符合率94%(Cohen κ=0.95),在类天疱疮患者中符合率71%(Cohen κ=0.66)。
- 与传统多步诊断方法比较,符合率在天疱疮中为91%(Cohen κ=0.95),在大疱性类天疱疮中为88%(Cohen κ=0.84),在自身抗体阴性血清中为93%(Cohen κ=0.78)。
关键数值与推荐
- 天疱疮与直接免疫荧光符合率94%,Cohen κ值0.95;类天疱疮符合率71%,Cohen κ值0.66。
- 与传统多步诊断符合率:天疱疮91%(κ=0.95),大疱性类天疱疮88%(κ=0.84),自身抗体阴性血清93%(κ=0.78)。
临床怎么用
- 该多变量ELISA可用于AIBD的常规血清学诊断,尤其适用于天疱疮,但类天疱疮的符合率相对较低需结合临床。
局限性
- 未分析IgA自身抗体和较少见的靶抗原。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Serologic diagnosis of autoimmune blistering disease (AIBD) usually follows a sophisticated multistep algorithm. OBJECTIVE: We sought validation of a multivariant enzyme-linked immunosorbent assay (ELISA) in the routine diagnosis of AIBD. METHODS: The multivariant ELISA comprising 6 recombinant immunodominant forms of major AIBD target antigens, ie, desmoglein 1, desmoglein 3, envoplakin, BP180, BP230, and type VII collagen was applied in: (1) a cohort of well-characterized AIBD (n = 173) and control sera (n = 130), (2) a prospective multicenter study with 204 sera from patients with newly diagnosed AIBD with positive direct immunofluorescence microscopy, and (3) a prospective monocenter study with 292 consecutive sera from patients with clinical suspicion of AIBD in comparison with the conventional multistep diagnostic algorithm. RESULTS: Concordant results in the multivariant ELISA compared with direct immunofluorescence microscopy were seen in 94% of patients with pemphigus and 71% of patients with pemphigoid (Cohen κ value, 0.95 and 0.66) and with the conventional multistep diagnostic approach in 91% of patients with pemphigus and 88% of patients with bullous pemphigoid and 93% of autoantibody-negative sera (Cohen κ, 0.95, 0.84, and 0.78). LIMITATIONS: IgA autoantibodies and less common target antigens were not analyzed. CONCLUSIONS: The multivariant ELISA is a practical, highly standardized, and widely available novel diagnostic tool for the routine diagnosis of AIBD.
引用
- van Beek N, Dähnrich C, Johannsen N, et al. Prospective studies on the routine use of a novel multivariant enzyme-linked immunosorbent assay for the diagnosis of autoimmune bullous diseases. J Am Acad Dermatol. 2016. PMID: 28038887. doi:10.1016/j.jaad.2016.11.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。